Company record
Medinatura New Mexico, Inc.
1 FDA warning letter since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Medinatura New Mexico, Inc..
Warning letters
-
DrugsMedinatura New Mexico, Inc.
FDA cited Medinatura New Mexico for drug manufacturing rule violations, including weak component testing and cleaning.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jan 14 | Class I | Medinatura New Mexico, inc. Drug |
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4006-9, UPC 787647101887 Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter. |
| Jan 14 | Class I | Medinatura New Mexico, inc. Drug |
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863 Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter. |